Team revises the role of cohesin in cancer

Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation. A good example of this is cohesin, a ring-shaped protein complex that embraces DNA to control cell division. Just a few months ago, and after several studies in the same direction, the sequencing of thousands of tumour samples identified the STAG2 gene—whose product forms part of cohesin—as one of the most frequently mutated genes in several types of cancer such as bladder cancer and melanoma.

The challenge now is to understand the link between cohesin and the development and evolution of cancer, an area where there is currently little data. Ana Losada, the head of the Chromosome Dynamics Group at the Spanish National Cancer Research Centre (CNIO), an international expert in cohesin, summarises in Nature Reviews Cancer the latest research on the role of cohesin, its regulation, as well as its recently identified function as a potential driver or facilitator for tumours.

According to the article, cohesin "prevents premature separation of sister chromatids [those that contain the duplicated before ]"; this facilitates both the equal distribution of the genetic material between each daughter cell as well as DNA repair.

"For a few years now, several studies have added a new role for these complexes in the maintenance of the 3D structure of the genome and gene expression", says Losada. In this case, cohesin intervenes during the interphase of the cell cycle, when the are not dividing, the longest stage in the of a cell's life.

This novel function, apart from the cell reproduction function, opens up a still-unknown field for the study of oncological diseases, which might help to understand the functional importance of cohesin mutations and their link to cancer.

Bladder cancer, a paradigmatic case

The review makes a special mention of several studies, in which STAG2 mutations are the most frequent, representing: "up to 30% of mutations in the lower grade tumours and up to 10-15% in the most aggressive ones".

Amongst the studies mentioned is a recent article coordinated by Francisco X. Real and Núria Malats at the CNIO. The researchers described how STAG2 mutations did not correlate with alterations in the genetic make-up of tumour cells. From their observations, the researchers concluded that: "the gene takes part in bladder cancer via different mechanisms to the distribution [of genetic material]".

Losada points out that a better understanding of cohesin biology, as well as the generation of new animal and cell models deficient in these proteins could contribute to an improvement in the diagnosis and treatment of patients.

Since her discovery of cohesin in vertebrate organisms at the end of the 1990s, Losada has continued to focus her research into this area of knowledge using different experimental models, such as the African frog Xenopus laevis or the mouse.

More information: Cohesin in cancer: chromosome segregation and beyond. Losada A. Nature Reviews Cancer (2014). DOI: 10.1038/nrc3743

add to favorites email to friend print save as pdf

Related Stories

CNIO researchers delve into the behavior of cohesins

Oct 18, 2013

Cohesins are protein complexes that join the two copies of each chromosome—called sister chromatids—to ensure that they are shared fairly between the daughter cells during cell division. In this way, ...

Non-infiltrating bladder cancer exome sequenced

Oct 13, 2013

Bladder cancer represents a serious public health problem in many countries, especially in Spain, where 11,200 new cases are recorded every year, one of the highest rates in the world. The majority of these ...

A skeleton for chromosomes

Aug 26, 2013

Researchers at the IMP Vienna discovered that cohesin stabilizes DNA. Jan-Michael Peters and his team at the Research Institute of Molecular Pathology (IMP) found that the structure of Chromosomes is supported ...

Genetic cause found for premature ovarian failure

Mar 05, 2014

A team led by researchers from the Spanish National Research Council and the University of Salamanca has found a genetic cause for premature ovarian failure, a disorder affecting 1 percent of women that provokes the loss ...

Recommended for you

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.